Changes in Alcohol Consumption following Direct-Acting Antiviral Treatment for Hepatitis C in VA Patients with Comorbid Alcohol Use Disorder and PTSD

References

• Anand, B. S., Currie, S., Dieperink, E., Bini, E. J., Shen, H., Ho, S. B., & Wright, T. (2006). Alcohol use and treatment of hepatitis C virus: Results of a national multicenter study. Gastroenterology, 130(6), 1607–1616. https://doi.org/10.1053/j.gastro.2006.02.023
   PubMed Web of Science ®Google Scholar
• Austin, P. C. (2009). Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Statistics in Medicine, 28(25), 3083–3107. https://doi.org/10.1002/sim.3697
   PubMed Web of Science ®Google Scholar
• Barua, S., Greenwald, R., Grebely, J., Dore, G. J., Swan, T., & Taylor, L. E. (2015). Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Annals of Internal Medicine, 163(3), 215–223. https://doi.org/10.7326/M15-0406
   PubMed Web of Science ®Google Scholar
• Belperio, P. S., Chartier, M., Ross, D. B., Alaigh, P., & Shulkin, D. (2017). Curing hepatitis C virus infection: Best practices from the U.S. Department of Veterans Affairs. Annals of Internal Medicine, 167(7), 499–504. https://doi.org/10.7326/M17-1073
   PubMed Web of Science ®Google Scholar
• Bernardy, N, F. M., & Schnurr, P. (2017). VA/DOD Clinical practice guideline for the management of post-traumatic stress disorder and acute stress disorder. https://www.healthquality.va.gov/guidelines/MH/ptsd/VADoDPTSDCPGFinal.pdf
   Google Scholar
• Bradley, K. A., Kivlahan, D. R., & Williams, E. C. (2009). Brief approaches to alcohol screening: Practical alternatives for primary care. Journal of General Internal Medicine, 24(7), 881–883. https://doi.org/10.1007/s11606-009-1014-9
   PubMed Web of Science ®Google Scholar
• Breen, M. S., Maihofer, A. X., Glatt, S. J., Tylee, D. S., Chandler, S. D., Tsuang, M. T., Risbrough, V. B., Baker, D. G., O'Connor, D. T., Nievergelt, C. M., & Woelk, C. H. (2015). Gene networks specific for innate immunity define post-traumatic stress disorder. Molecular Psychiatry, 20(12), 1538–1545. https://doi.org/10.1038/mp.2015.9
   PubMed Web of Science ®Google Scholar
• Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D., & Bradley, K. A. (1998). The AUDIT alcohol consumption questions (AUDIT-C): An effective brief screening test for problem drinking. Alcohol Use Disorders Identification Test. Archives of Internal Medicine, 158(16), 1789–1795. https://doi.org/10.1001/archinte.158.16.1789
   PubMed Web of Science ®Google Scholar
• Butt, A. A., Justice, A. C., Skanderson, M., Rigsby, M. O., Good, C. B., & Kwoh, C. K. (2007). Rate and predictors of treatment prescription for hepatitis C. Gut, 56(3), 385–389. https://doi.org/10.1136/gut.2006.099150
   PubMed Web of Science ®Google Scholar
• Casella, G., Rasouli, J., Mason, K., Boehm, A., Kumar, G., Hwang, D., Thome, R., Ishikawa, L., Zhang, G.-X., Ciric, B., & Rostami, A. (2020). A serine protease inhibitor suppresses autoimmune neuroinflammation by activating the STING/IFN-β axis in macrophages. Cellular & Molecular Immunology, 17(12), 1278–1280. https://doi.org/10.1038/s41423-020-0405-z
   PubMed Web of Science ®Google Scholar
• Çelik, S., Kayaaltı, A., & Erbas, O. (2022). NLRP3 inflammasome: A new target in psychiatric disorders. CNS Neuroscience and Theraputics, 2, 392–398. https://doi.org/10.5606/jebms.2021.75681
   Google Scholar
• Chang, A., Skole, K., Gautam, M., Schmutz, J., Black, M., Thomas, R., Horwitz, B., & Friedenberg, F. (2005). The impact of past alcohol use on treatment response rates in patients with chronic hepatitis C. Alimentary Pharmacology and Therapeutics, 22(8), 701–706. https://doi.org/10.1111/j.1365-2036.2005.02631.x
   PubMed Web of Science ®Google Scholar
• Chen, W., Xu, Y., Li, H., Tao, W., Xiang, Y., Huang, B., Niu, J., Zhong, J., & Meng, G. (2014). HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells. PLoS One, 9(1), e84953. https://doi.org/10.1371/journal.pone.0084953
   PubMed Web of Science ®Google Scholar
• Cheon, S. Y., Kim, J., Kim, S. Y., Kim, E. J., & Koo, B.-N. (2020). Inflammasome and cognitive symptoms in human diseases: Biological evidence from experimental research. International Journal of Molecular Sciences, 21(3), 1103. https://doi.org/10.3390/ijms21031103
   Web of Science ®Google Scholar
• Debell, F., Fear, N. T., Head, M., Batt-Rawden, S., Greenberg, N., Wessely, S., & Goodwin, L. (2014). A systematic review of the comorbidity between PTSD and alcohol misuse. Social Psychiatry and Psychiatric Epidemiology, 49(9), 1401–1425. https://doi.org/10.1007/s00127-014-0855-7
   PubMed Web of Science ®Google Scholar
• Dong, Y., Li, S., Lu, Y., Li, X., Liao, Y., Peng, Z., Li, Y., Hou, L., Yuan, Z., & Cheng, J. (2020). Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice. Journal of Neuroinflammation, 17(1), 205. https://doi.org/10.1186/s12974-020-01842-0
   PubMed Web of Science ®Google Scholar
• Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Di Paola, R. (2020). Focus on the role of NLRP3 inflammasome in diseases. International Journal of Molecular Sciences, 21(12), 4223. https://doi.org/10.3390/ijms21124223
   PubMed Web of Science ®Google Scholar
• Gal-Ben-Ari, S., Barrera, I., Ehrlich, M., & Rosenblum, K. (2018). PKR: A kinase to remember [Review]. Frontiers in Molecular Neuroscience, 11, 480. https://doi.org/10.3389/fnmol.2018.00480
   PubMed Web of Science ®Google Scholar
• Giovannini, C., Fornari, F., Indio, V., Trerè, D., Renzulli, M., Vasuri, F., Cescon, M., Ravaioli, M., Perrucci, A., Astolfi, A., Piscaglia, F., & Gramantieri, L. (2020). Direct antiviral treatments for hepatitis C virus have off-target effects of oncologic relevance in hepatocellular carcinoma. Cancers, 12(9), 2674. https://doi.org/10.3390/cancers12092674
   Web of Science ®Google Scholar
• Gupta, S. C., Sundaram, C., Reuter, S., & Aggarwal, B. B. (2010). Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochimica et Biophysica Acta, 1799(10–12), 775–787. https://doi.org/10.1016/j.bbagrm.2010.05.004
   PubMed Web of Science ®Google Scholar
• He, Y., Tan, S.-L., Tareen, S. U., Vijaysri, S., Langland, J. O., Jacobs, B. L., & Katze, M. G. (2001). Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A. Journal of Virology, 75(11), 5090–5098. https://doi.org/10.1128/JVI.75.11.5090-5098.2001
   PubMed Web of Science ®Google Scholar
• Herink, M. C., Geddes, J., Vo, K., Zaman, A., & Hartung, D. M. (2021). Effect of relaxing hepatitis C treatment restrictions on direct-acting antiviral use in a Medicaid program: An interrupted time series analysis. Journal of Managed Care & Specialty Pharmacy, 27(7), 856–864. https://doi.org/10.18553/jmcp.2021.27.7.856
   PubMed Web of Science ®Google Scholar
• Hoyt, L. R., Ather, J. L., Randall, M. J., DePuccio, D. P., Landry, C. C., Wewers, M. D., Gavrilin, M. A., & Poynter, M. E. (2016). Ethanol and other short-chain alcohols inhibit NLRP3 inflammasome activation through protein tyrosine phosphatase stimulation. Journal of Immunology, 197(4), 1322–1334. https://doi.org/10.4049/jimmunol.1600406
   PubMed Web of Science ®Google Scholar
• Infectious Diseases Society of America (2021). HCV guidance: Recommendations for testing, managing, and treating hepatis C. https://www.hcvguidelines.org/
   Google Scholar
• Jackson, W. E., & Everson, G. T. (2017). Sofosbuvir and velpatasvir for the treatment of hepatitis C. Expert Review of Gastroenterology & Hepatology, 11(6), 501–505. https://doi.org/10.1080/17474124.2017.1326817
   PubMed Web of Science ®Google Scholar
• Kapil, P., Stohlman, S. A., Hinton, D. R., & Bergmann, C. C. (2014). PKR mediated regulation of inflammation and IL-10 during viral encephalomyelitis. Journal of Neuroimmunology, 270(1–2), 1–12. https://doi.org/10.1016/j.jneuroim.2014.02.012
   PubMed Web of Science ®Google Scholar
• Khan, A., Tansel, A., White, D. L., Kayani, W. T., Bano, S., Lindsay, J., El-Serag, H. B., & Kanwal, F. (2016). Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: A systematic review. Clinical Gastroenterology and Hepatology, 14(2), 191–202. https://doi.org/10.1016/j.cgh.2015.07.047
   PubMed Web of Science ®Google Scholar
• Kim, N. J., Pearson, M., Vutien, P., Su, F., Moon, A. M., Berry, K., Green, P. K., Williams, E. C., & Ioannou, G. N. (2020). Alcohol use and long-term outcomes among U.S. veterans who received direct-acting antivirals for hepatitis C treatment. Hepatology Communications, 4(2), 314–324. https://doi.org/10.1002/hep4.1464
   PubMed Web of Science ®Google Scholar
• Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., Bernstein, D. E., Lawitz, E., Shiffman, M. L., Schiff, E., Ghalib, R., Ryan, M., Rustgi, V., Chojkier, M., Herring, R., Di Bisceglie, A. M., Pockros, P. J., Subramanian, G. M., An, D., Svarovskaia, E., Hyland, R. H., … Fried, M. W. (2014). Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. The New England Journal of Medicine, 370(20), 1879–1888. https://doi.org/10.1056/NEJMoa1402355
   PubMed Web of Science ®Google Scholar
• Kranzler, H. R., & Soyka, M. (2018). Diagnosis and pharmacotherapy of alcohol use disorder: A Review. JAMA, 320(8), 815–824. https://doi.org/10.1001/jama.2018.11406
   PubMed Web of Science ®Google Scholar
• Kwako, L. E., Schwandt, M. L., Sells, J. R., Ramchandani, V. A., Hommer, D. W., George, D. T., Sinha, R., & Heilig, M. (2015). Methods for inducing alcohol craving in individuals with co-morbid alcohol dependence and posttraumatic stress disorder: Behavioral and physiological outcomes. Addiction Biology, 20(4), 733–746. https://doi.org/10.1111/adb.12150
   PubMed Web of Science ®Google Scholar
• Lamb, Y. N. (2017). Glecaprevir/pibrentasvir: First global approval. Drugs, 77(16), 1797–1804. https://doi.org/10.1007/s40265-017-0817-y
   PubMed Web of Science ®Google Scholar
• Lan, T., Tao, A., Xu, X., Kvietys, P., & Rui, T. (2020). Peroxynitrite/PKR axis modulates the NLRP3 inflammasome of cardiac fibroblasts. Frontiers in Immunology, 11, 558712. https://doi.org/10.3389/fimmu.2020.558712
   PubMed Web of Science ®Google Scholar
• Lowe, P. P., Cho, Y., Tornai, D., Coban, S., Catalano, D., & Szabo, G. (2020). Inhibition of the inflammasome signaling cascade reduces alcohol consumption in female but not male mice. Alcoholism: Clinical and Experimental Research, 44(2), 567–578. https://doi.org/10.1111/acer.14272
   PubMed Web of Science ®Google Scholar
• Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundbäck, P., Valdes-Ferrer, S. I., Olofsson, P. S., Kalb, T., Roth, J., Zou, Y., Erlandsson-Harris, H., Yang, H., Ting, J. P., Wang, H., Andersson, U., Antoine, D. J., Chavan, S. S., Hotamisligil, G. S., & Tracey, K. J. (2012). Novel role of PKR in inflammasome activation and HMGB1 release. Nature, 488(7413), 670–674. https://doi.org/10.1038/nature11290
   PubMed Web of Science ®Google Scholar
• Maguen, S., Holder, N., Madden, E., Li, Y., Seal, K. H., Neylan, T. C., Lujan, C., Patterson, O. V., DuVall, S. L., & Shiner, B. (2020). Evidence-based psychotherapy trends among posttraumatic stress disorder patients in a national healthcare system, 2001–2014. Depression and Anxiety, 37(4), 356–364. https://doi.org/10.1002/da.22983
   PubMed Web of Science ®Google Scholar
• Maguen, S., Madden, E., Patterson, O. V., DuVall, S. L., Goldstein, L. A., Burkman, K., & Shiner, B. (2018). Measuring use of evidence based psychotherapy for posttraumatic stress disorder in a large national healthcare system. Administration and Policy in Mental Health, 45(4), 519–529. https://doi.org/10.1007/s10488-018-0850-5
   PubMed Web of Science ®Google Scholar
• Marshall, C. C., & Szabo, G. (2021). Hepatitis C and alcohol. Retrieved February 24, 2022, from https://www.uptodate.com/contents/hepatitis-c-and-alcohol?search=hepatitis%20c%20and%20alcohol&source=search_result&selectedTitle=1∼150&usage_type=default&display_rank=1
   Google Scholar
• McCaffrey, D. F., Griffin, B. A., Almirall, D., Slaughter, M. E., Ramchand, R., & Burgette, L. F. (2013). A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Statistics in Medicine, 32(19), 3388–3414. https://doi.org/10.1002/sim.5753
   PubMed Web of Science ®Google Scholar
• McLean, C. P., Su, Y. J., & Foa, E. B. (2015). Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence. Journal of Consulting and Clinical Psychology, 83(3), 655–661. https://doi.org/10.1037/ccp0000024
   PubMed Web of Science ®Google Scholar
• Memon, M. I., & Memon, M. A. (2002). Hepatitis C: An epidemiological review. Journal of Viral Hepatitis, 9(2), 84–100. https://doi.org/10.1046/j.1365-2893.2002.00329.x
   PubMed Web of Science ®Google Scholar
• Nennig, S. E., & Schank, J. R. (2017). The role of NFkB in drug addiction: Beyond inflammation. Alcohol and Alcoholism, 52(2), 172–179. https://doi.org/10.1093/alcalc/agw098
   PubMed Web of Science ®Google Scholar
• Okazaki, T., Yoshihara, H., Suzuki, K., Yamada, Y., Tsujimura, T., Kawano, K., Yamada, Y., & Abe, H. (1994). Efficacy of interferon therapy in patients with chronic hepatitis C: Comparison between non-drinkers and drinkers. Scandinavian Journal of Gastroenterology, 29(11), 1039–1043. https://doi.org/10.3109/00365529409094883
   PubMed Web of Science ®Google Scholar
• Owens, M. D., Ioannou, G. N., Tsui, J. L., Edelman, E. J., Greene, P. A., & Williams, E. C. (2018). Receipt of alcohol-related care among patients with HCV and unhealthy alcohol use. Drug and Alcohol Dependence, 188, 79–85. https://doi.org/10.1016/j.drugalcdep.2018.03.047
   PubMed Web of Science ®Google Scholar
• Pietrzak, R. H., Goldstein, R. B., Southwick, S. M., & Grant, B. F. (2011). Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: Results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Anxiety Disorders, 25(3), 456–465. https://doi.org/10.1016/j.janxdis.2010.11.010
   PubMed Web of Science ®Google Scholar
• Price, L. E., Shea, K., & Gephart, S. (2015). The Veterans Affairs’s Corporate Data Warehouse: Uses and implications for nursing research and practice. Nursing Administration Quarterly, 39(4), 311–318. https://doi.org/10.1097/NAQ.0000000000000118
   PubMedGoogle Scholar
• Proeschold-Bell, R. J., Evon, D. M., Yao, J., Niedzwiecki, D., Makarushka, C., Keefe, K. A., Patkar, A. A., Mannelli, P., Garbutt, J. C., Wong, J. B., Wilder, J. M., Datta, S. K., Hodge, T., Naggie, S., Fried, M. W., & Muir, A. J. (2020). A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. Hepatology, 71(6), 1894–1909. https://doi.org/10.1002/hep.31058
   PubMed Web of Science ®Google Scholar
• Ramachandran, A., Kumar, B., Waris, G., & Everly, D. (2021). Deubiquitination and activation of the NLRP3 inflammasome by UCHL5 in HCV-infected cells. Microbiology Spectrum, 9(1), e0075521. https://doi.org/10.1128/Spectrum.00755-21
   PubMed Web of Science ®Google Scholar
• Rentsch, C. T., Cartwright, E. J., Gandhi, N. R., Brown, S. T., Rodriguez-Barradas, M. C., Goetz, M. B., Marconi, V. C., Gibert, C. L., Re, V. L. III, Fiellin, D. A., Justice, A. C., & Tate, J. P. (2018). Provider verification of electronic health record receipt and nonreceipt of direct-acting antivirals for the treatment of hepatitis C virus infection. Annals of Epidemiology, 28(11), 808–811. https://doi.org/10.1016/j.annepidem.2018.08.007
   PubMed Web of Science ®Google Scholar
• Rubinsky, A. D., Dawson, D. A., Williams, E. C., Kivlahan, D. R., & Bradley, K. A. (2013). AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers. Alcoholism: Clinical and Experimental Research, 37(8), 1380–1390. https://doi.org/10.1111/acer.12092
   PubMed Web of Science ®Google Scholar
• Seal, K. H., Cohen, G., Bertenthal, D., Cohen, B. E., Maguen, S., & Daley, A. (2011). Reducing barriers to mental health and social services for Iraq and Afghanistan veterans: Outcomes of an integrated primary care clinic. Journal of General Internal Medicine, 26(10), 1160–1167. https://doi.org/10.1007/s11606-011-1746-1
   PubMed Web of Science ®Google Scholar
• Seal, K. H., Cohen, G., Waldrop, A., Cohen, B. E., Maguen, S., & Ren, L. (2011). Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001–2010: Implications for screening, diagnosis and treatment. Drug and Alcohol Dependence, 116(1–3), 93–101. https://doi.org/10.1016/j.drugalcdep.2010.11.027
   PubMed Web of Science ®Google Scholar
• Sharma, B. R., & Kanneganti, T.-D. (2021). NLRP3 inflammasome in cancer and metabolic diseases. Nature Immunology, 22(5), 550–559. https://doi.org/10.1038/s41590-021-00886-5
   PubMed Web of Science ®Google Scholar
• Shiner, B., Forehand, J. A., Rozema, L., Kulldorff, M., Watts, B. V., Trefethen, M., Jiang, T., Huybrechts, K. F., Schnurr, P. P., Vincenti, M., Gui, J., & Gradus, J. L. (2022). Mining clinical data for novel posttraumatic stress disorder medications. Biological Psychiatry, 91(7), 647–657. https://doi.org/10.1016/j.biopsych.2021.10.008
   PubMed Web of Science ®Google Scholar
• Shiner, B., Huybrechts, K., Gui, J., Rozema, L., Forehand, J., Watts, B. V., Jiang, T., Hoyt, J. E., Esteves, J., Schnurr, P. P., Ray, K., & Gradus, J. L. (2022). Comparative effectiveness of direct-acting antivirals for posttraumatic stress disorder in VA patients with hepatitis C virus infection. American Journal of Epidemiology, 191(9), 1614–1625. https://doi.org/10.1093/aje/kwac104
   PubMed Web of Science ®Google Scholar
• Shiner, B., Leonard Westgate, C., Simiola, V., Thompson, R., Schnurr, P. P., & Cook, J. M. (2018). Measuring use of evidence-based psychotherapy for PTSD in VA residential treatment settings with clinician survey and electronic medical record templates. Military Medicine, 183(9–10), e539–e546. https://doi.org/10.1093/milmed/usy008
   PubMed Web of Science ®Google Scholar
• Shiner, B., Peltzman, T., Cornelius, S. L., Gui, J., Forehand, J., & Watts, B. V. (2021). Recent trends in the rural-urban suicide disparity among veterans using VA health care. Journal of Behavioral Medicine, 44(4), 492–506. https://doi.org/10.1007/s10865-020-00176-9
   PubMed Web of Science ®Google Scholar
• Shiner, B., Tang, C., Trapp, A. C., Konrad, R., Bar-On, I., & Watts, B. V. (2014). The provision of mental health treatment after screening: exploring the relationship between treatment setting and treatment intensity. General Hospital Psychiatry, 36(6), 581–588. https://doi.org/10.1016/j.genhosppsych.2014.07.009
   PubMed Web of Science ®Google Scholar
• Singal, A. K., & Anand, B. S. (2007). Mechanisms of synergy between alcohol and hepatitis C virus. Journal of Clinical Gastroenterology, 41(8), 761–772. https://doi.org/10.1097/MCG.0b013e3180381584
   PubMed Web of Science ®Google Scholar
• Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., S. Sulkowski, M., Torriani, F. J., Dieterich, D. T., Thomas, D. L., Messinger, D., & Nelson, M. (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology, 43(6), 1317–1325. https://doi.org/10.1002/hep.21178
   PubMed Web of Science ®Google Scholar
• Stuart, E. A. (2010). Matching methods for casual inference: A review and a look forward. Statistical Science, 25(1), 1–21. https://doi.org/10.1214/09-STS313
   PubMed Web of Science ®Google Scholar
• Suzuki, R., Matsuda, M., Shimoike, T., Watashi, K., Aizaki, H., Kato, T., Suzuki, T., Muramatsu, M., & Wakita, T. (2019). Activation of protein kinase R by hepatitis C virus RNA-dependent RNA polymerase. Virology, 529, 226–233. https://doi.org/10.1016/j.virol.2019.01.024
   PubMed Web of Science ®Google Scholar
• Swift, R. M., & Aston, E. R. (2015). Pharmacotherapy for alcohol use disorder: Current and emerging therapies. Harvard Review of Psychiatry, 23(2), 122–133. https://doi.org/10.1097/HRP.0000000000000079
   PubMed Web of Science ®Google Scholar
• Tsui, J. I., Williams, E. C., Green, P. K., Berry, K., Su, F., & Ioannou, G. N. (2016). Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents. Drug and Alcohol Dependence, 169, 101–109. https://doi.org/10.1016/j.drugalcdep.2016.10.021
   PubMed Web of Science ®Google Scholar
• Tucker, J. A., Chandler, S. D., & Witkiewitz, K. (2020). Epidemiology of recovery from alcohol use disorder. Alcohol Research: Current Reviews, 40(3), 2. https://doi.org/10.35946/arcr.v40.3.02
   PubMed Web of Science ®Google Scholar
• U.S. Department of Veterans Affairs (2016). VA expands hepatitis C drug treatment [Press release]. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=2762
   Google Scholar
• Vallet-Pichard, A., Mallet, V., Nalpas, B., Verkarre, V., Nalpas, A., Dhalluin-Venier, V., Fontaine, H., & Pol, S. (2007). FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology, 46(1), 32–36. https://doi.org/10.1002/hep.21669
   PubMed Web of Science ®Google Scholar
• Wang, Z., Zhang, S., Xiao, Y., Zhang, W., Wu, S., Qin, T., Yue, Y., Qian, W., & Li, L. (2020). NLRP3 inflammasome and inflammatory diseases. Oxidative Medicine and Cellular Longevity, 2020, 4063562. https://doi.org/10.1155/2020/4063562
   PubMed Web of Science ®Google Scholar
• Watkins, L. E., Sprang, K. R., & Rothbaum, B. O. (2018). Treating PTSD: A review of evidence-based psychotherapy interventions. Frontiers in Behavioral Neuroscience, 12, 258. https://doi.org/10.3389/fnbeh.2018.00258
   PubMed Web of Science ®Google Scholar
• Westbrook, R. H., & Dusheiko, G. (2014). Natural history of hepatitis C. Journal of Hepatology, 61(1 Suppl), S58–S68. https://doi.org/10.1016/j.jhep.2014.07.012
   PubMedGoogle Scholar
• Wohleb, E. S., McKim, D. B., Sheridan, J. F., & Godbout, J. P. (2014). Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Frontiers in Neuroscience, 8, 447. https://doi.org/10.3389/fnins.2014.00447
   PubMed Web of Science ®Google Scholar
• Yamanashi, T., Iwata, M., Shibushita, M., Tsunetomi, K., Nagata, M., Kajitani, N., Miura, A., Matsuo, R., Nishiguchi, T., Kato, T. A., Setoyama, D., Shirayama, Y., Watanabe, K., Shinozaki, G., & Kaneko, K. (2020). Beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, attenuates anxiety-related behavior in a rodent post-traumatic stress disorder model. Scientific Reports, 10(1), 21629. https://doi.org/10.1038/s41598-020-78410-2
   PubMed Web of Science ®Google Scholar
• Zhang, L., Alter, H. J., Wang, H., Jia, S., Wang, E., Marincola, F. M., Shih, J. W., & Wang, R. Y. (2013). The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells. Virology, 438(1), 28–36. https://doi.org/10.1016/j.virol.2013.01.015
   PubMed Web of Science ®Google Scholar